Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.73 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.68 |
| ▸ | TFPI | P10646 | 4/20 | 0.68 |
| ▸ | CCKBR | P32239 | 2/20 | 0.65 |
| ▸ | GLP1R | P43220 | 2/20 | 0.65 |
| ▸ | NPY2R | P49146 | 6/20 | 0.65 |
| ▸ | NPY4R | P50391 | 6/20 | 0.65 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.65 |
| ▸ | NPY1R | P25929 | 4/20 | 0.65 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.64 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783629 | 1.00 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783636 | 1.00 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783631 | 1.00 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783626 | 1.00 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783640 | 1.00 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783627 | 0.99 | CALCR (0.72) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783634 | 0.99 | CALCR (0.72) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783639 | 0.99 | CALCR (0.72) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783630 | 0.99 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R | |
| SCHEMBL29783632 | 0.99 | CALCR (0.73) | CALCRRAMP3TFPICCKBRGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12103951-B2 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | SOARES CHRISTOPHER JOSEPH (US) | 2024-10-01 | — | — | US | claimed |
| EP-4316595-A2 | USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA | Soares, Christopher, J. (US) | 2024-02-07 | — | — | EP | claimed |
| EP-3506925-B1 | USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA | SOARES CHRISTOPHER J (US) | 2023-09-06 | — | — | EP | claimed |
| US-20230212248-A1 | USE OF CGRP RECEPTOR ANTAGONISTS IN NEUROPROTECTION AND NEUROLOGICAL DISORDERS | SOARES CHRISTOPHER JOSEPH (US) | 2023-07-06 | — | — | US | claimed |
| US-11390654-B2 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | SOARES CHRISTOPHER JOSEPH (US) | 2022-07-19 | — | — | US | claimed |
| US-12103951-B2 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | SOARES CHRISTOPHER JOSEPH (US) | 2024-10-01 | — | — | US | disclosed |
| EP-4316595-A2 | USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA | Soares, Christopher, J. (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-3506925-B1 | USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA | SOARES CHRISTOPHER J (US) | 2023-09-06 | — | — | EP | disclosed |
| US-20230212248-A1 | USE OF CGRP RECEPTOR ANTAGONISTS IN NEUROPROTECTION AND NEUROLOGICAL DISORDERS | SOARES CHRISTOPHER JOSEPH (US) | 2023-07-06 | — | — | US | disclosed |
| US-11390654-B2 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | SOARES CHRISTOPHER JOSEPH (US) | 2022-07-19 | — | — | US | disclosed |